DanielFitzgeraldMD
Family Medicine • Catskill, NYAssociate Professor, Medicine, Weill Cornell Medical College
Are you Dr. Fitzgerald?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
159 Jefferson Hts
Ste D108
Catskill, NY 12414Phone+1 518-943-3415Fax+1 518-943-0938
Summary
- Dr. Daniel Fitzgerald, MD is a board certified family physician in Catskill, New York. He is currently licensed to practice medicine in New York. He is affiliated with Columbia Memorial Hospital and is an Associate Professor at Weill Cornell Medical College.
Education & Training
Institute for Family Health (Mid-Hudson)Residency, Family Medicine, 2013 - 2016
Yale School of MedicineClass of 1992
Certifications & Licensure
NY State Medical License 2016 - 2026- American Board of Family Medicine Family Medicine
Publications & Presentations
PubMed
- 1 citationsA social worker intervention to reduce post-hospital mortality in HIV-infected adults in Tanzania (Daraja): Study protocol for a randomized controlled trial.Godfrey A Kisigo, Benson Issarow, Kelvin Abel, Ramadhan Hashim, Elialilia S Okello
Contemporary Clinical Trials. 2022-02-01 - 21 citationsTraditional healer-delivered point-of-care HIV testing versus referral to clinical facilities for adults of unknown serostatus in rural Uganda: a mixed-methods, cluste...Radhika Sundararajan, Matthew Ponticiello, Myung Hee Lee, Steffanie A. Strathdee, Winnie Muyindike
The Lancet. Global Health. 2021-11-01 - 3 citationsPoint-of-care viral load testing among adolescents and young adults living with HIV in Haiti: a randomized control trial.Lindsey K Reif, Marie Elmase Belizaire, Vanessa Rouzier, Grace Seo, Patrice Severe
AIDS Care. 2021-10-06
Press Mentions
As ASCO 2021 Spotlights Biomarkers, New InCrowd Data Shows 80% of US Oncologists Anticipate Broader Liquid Biomarkers Use, Despite Insurance BarriersJune 2nd, 2021
Demarest's Global Health Expert: Dr. Warren Johnson JrMarch 8th, 2016
